Oral nanozyme treats colitis-linked mental disorders via gut-brain axis
Nanotechnology and Emerging Technologies News from Nanowerk [Un…
February 19, 2026
Oral polysaccharide-engineered nanozyme treats colitis-linked mental disorders by targeting oxidative stress and gut dysbiosis via the microbiome-gut-brain axis.
Discussion in the ATmosphere